NOT FDA-APPROVED FOR ANY USE
What is AHK-Cu?
AHK-Cu (alanyl-histidyl-lysine copper complex) is a copper-binding tripeptide structurally related to GHK-Cu. It has drawn interest in early cosmetic and dermatological research, though it is less extensively studied than its better-known relative.
Areas of Research Interest
- Skin repair and regeneration studies
- Collagen production research
- Early-stage cosmetic formulation studies
- Comparative research alongside GHK-Cu
Regulatory Status
AHK-Cu is not FDA-approved as a drug for any use. Research on this compound remains more limited than related copper peptides, and it is intended solely for laboratory and cosmetic-formulation research settings.
Educational information only. This content is not intended to diagnose, treat, cure, or prevent any disease, and does not provide guidance on personal use, dosing, or administration. Consult qualified professionals and current regulatory sources for guidance specific to your situation.